Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

BACKGROUND: Thiopurines (azathioprine and mercaptopurine) remain integral to most medical strategies for maintaining remission in Crohn's disease (CD) and ulcerative colitis (UC). Indefinite use of these drugs is tempered by long-term risks. While clinical relapse is noted frequently following...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, N A, Kalla, R, Warner, B, Gambles, C J, Musy, R, Reynolds, S, Dattani, R, Nayee, H, Felwick, R, Harris, R, Marriott, S, Senanayake, S M, Lamb, C A, Al-Hilou, H, Gaya, D R, Irving, P M, Mansfield, J, Parkes, M, Ahmad, T, Cummings, J R F, Arnott, I D, Satsangi, J, Lobo, A J, Smith, M, Lindsay, J O, Lees, C W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Thiopurine Withdrawal in Ibd
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232866/
https://www.ncbi.nlm.nih.gov/pubmed/25284134
http://dx.doi.org/10.1111/apt.12980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232866/
https://www.ncbi.nlm.nih.gov/pubmed/25284134
http://dx.doi.org/10.1111/apt.12980

Ejemplares similares